P16INK4a overexpression is associated with poor clinical outcome in ovarian carcinoma

J Chemother. 2004 Aug;16(4):411-3. doi: 10.1179/joc.2004.16.4.411.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma, Clear Cell / chemistry*
  • Adenocarcinoma, Clear Cell / mortality*
  • Adenocarcinoma, Clear Cell / therapy
  • Adult
  • Aged
  • Biomarkers, Tumor / analysis*
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Cyclin-Dependent Kinase Inhibitor p16 / analysis*
  • Female
  • Humans
  • Hysterectomy / methods
  • Middle Aged
  • Neoplasm Recurrence, Local / chemistry
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Staging
  • Ovarian Neoplasms / chemistry*
  • Ovarian Neoplasms / mortality*
  • Ovarian Neoplasms / therapy
  • Ovariectomy / methods
  • Prognosis
  • Prospective Studies
  • Risk Assessment
  • Sensitivity and Specificity
  • Survival Rate

Substances

  • Biomarkers, Tumor
  • Cyclin-Dependent Kinase Inhibitor p16